BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5067201)

  • 1. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 4. Effects on erythrocyte membrane lysis and on red cells aggregation.
    Coppi G; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:247-9. PubMed ID: 5067201
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Action on local and systemic chemical responses in the rat with an experimental inflammatory process.
    Coppi G; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:237+. PubMed ID: 5067200
    [No Abstract]   [Full Text] [Related]  

  • 3. Survey of the biological properties of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370), a novel agent in the class of anti-inflammatory drugs.
    Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:249-5. PubMed ID: 5067202
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. General pharmacological properties.
    Bianchi C; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:196+. PubMed ID: 5067191
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. Enzyme induction and interaction with other drugs in the rat.
    Coppi G; Vidi A; Vanoni PC; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:242-6. PubMed ID: 4111897
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
    Coppi G; Bonardi G; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
    Marazzi-Uberti E; Bianchi C; Gaetani M; Pozzi L
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 5. Activity on acute experimental synovitis in dogs.
    Lumachi B
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:202-4. PubMed ID: 5067193
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Subacute and chronic toxicity in rats and dogs.
    Gaetani M; Debeus R; Bonardi G; Coppi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:216+. PubMed ID: 5067196
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of new antirheumatic-antiphlogistic agents on heat-induced hemolysis of human erythrocytes in vitro].
    Kalbhen DA; Loyen R
    Arzneimittelforschung; 1973 Jul; 23(7):945-9. PubMed ID: 4800450
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 6. Activity on polyarthritis induced in rats by Freund's adjuvant.
    Lumachi B
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:204+. PubMed ID: 5067194
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro.
    Roubal Z; Grimová J; Nĕmecek O; Cepelák V
    Acta Univ Carol Med Monogr; 1972; 53():229-35. PubMed ID: 4133930
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. A comparative study of short-term toxicity of DA 2370 and other non-steroid anti-inflammatory drugs (phenylbutazone, mefenamic acid, indometacin and benzydamine) in the rat.
    Gaetani M; Debeus R; Vidi A; Coppi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:226-3. PubMed ID: 5067198
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Anti-inflammatory, analgesic and antipyretic properties.
    Bianchi C; Lumachi B; Marazzi-Uberti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:183+. PubMed ID: 5067190
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 7. Pharmacological comparison with standard anti-inflammatory drugs.
    Marazzi-Uberti E; Lumachi B; Gaetani M; Coppi G; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:213-6. PubMed ID: 5067195
    [No Abstract]   [Full Text] [Related]  

  • 16. Mode of stabilizing action of non-steroid anti-inflammatory drugs on erythrocyte membrane.
    Mizushima Y; Sakai S; Yamaura M
    Biochem Pharmacol; 1970 Jan; 19(1):227-34. PubMed ID: 5534110
    [No Abstract]   [Full Text] [Related]  

  • 17. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.
    Casadio S; Pala G; Marazzi-Uberti E; Lumachi B; Crescenzi E; Donetti A; Mantegani A; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of membrane sialic acid and glycophorin protein in thorium induced aggregation and hemolysis of human erythrocytes.
    Kumar A; Ali M; Pandey BN; Hassan PA; Mishra KP
    Biochimie; 2010 Jul; 92(7):869-79. PubMed ID: 20362640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and clinical effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Ghiringhelli F; Mazzi C; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:268-7. PubMed ID: 5067203
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological studies of N-benzoyl-N'-phenyl-2,6-diaminobenzoic acid (F1). 3. Interaction with proteins].
    Fujimura H; Tsurumi K; Abe A; Hayashi M; Nakano K
    Nihon Yakurigaku Zasshi; 1973 Nov; 69(6):918-29. PubMed ID: 4799521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.